Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III-Reference-Cited by-同舟云学术

Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III

Published:2017-02-01 Issue:6 Volume:281 Page:575-585
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Ghosh Laskar M.¹²³,Eriksson M.¹,Rudling M.¹²³,Angelin B.¹²³

Affiliation:

1. Metabolism Unit; Department of Endocrinology, Metabolism and Diabetes; Karolinska Institutet; Karolinska University Hospital; Huddinge Stockholm Sweden

2. Molecular Nutrition Unit; Center for Innovative Medicine (CIMED); Karolinska Institutet; Karolinska University Hospital; Huddinge Stockholm Sweden

3. KI/AZ Integrated CardioMetabolic Center (ICMC); Department of Medicine; Karolinska Institutet; Karolinska University Hospital; Huddinge Stockholm Sweden

Funder

Vetenskapsrådet

Kommunfullmäktige, Stockholms Stad

Hjärt-Lungfonden

Leducq Foundation

NovoNordisk Foundation

Knut och Alice Wallenbergs Stiftelse

Cardiovascular Program of Karolinska Institute/Stockholm County Council

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12594/fullpdf

Reference48 articles.

1. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids;Bramlett;Mol Genet Metab,2000

2. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription;Chiang;J Biol Chem,2000

3. Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism;Adler;Gastroenterology,1975

4. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients;LaRusso;Gastroenterology,1975

5. The effect of chenodeoxycholic acid feeding on bile acid kinetics and fecal neutral steroid excretion in patients with hyperlipoproteinemia types II and IV;Kallner;J Lab Clin Med,1975

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotransformation of chenodeoxycholic acid by human intestinal fungi and the agonistic effects on FXR;Phytochemistry;2024-08

2. Chenodeoxycholic Acid‐Modified Polyethyleneimine Nano‐Composites Deliver Low‐Density Lipoprotein Receptor Genes for Lipid‐Lowering Therapy by Targeting the Liver;Advanced Healthcare Materials;2024-06-16

3. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2024-04-26

4. The role of bile acid metabolism in bone and muscle: from analytics to mechanisms;Critical Reviews in Clinical Laboratory Sciences;2024-03-15

5. Lipoprotein-mimicking nanotherapeutics reconstituted with chenodeoxycholic acid modified protein for efficient tumor targeting;European Journal of Pharmaceutics and Biopharmaceutics;2024-03